<?xml version="1.0"?>
<rss version="2.0">
  <channel>
    <title>RxPG News : GAD</title>
      <link>http://www.rxpgnews.com/</link>
      <description>Medical News and Information</description>
      <pubDate>Thu, 25 Oct 2007 07:48:36 PST</pubDate>
      <language>en-us</language>
      <item>
        <title>Pregabalin Receives a Positive Opinion from CHMP for the Treatment of Generalized Anxiety Disorder in Adults</title>
        <link>http://www.rxpgnews.com/generalisedanxietydisorder/Pregabalin_Receives_a_Positive_Opinion_from_CHMP_f_3304_3304.shtml</link>
        <category>GAD</category>
        <description>Pfizer Inc said that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency issued a positive opinion recommending marketing authorization of Lyrica® (pregabalin), a novel mechanism for the treatment of generalized anxiety disorder (GAD) in adults.</description>
        <pubDate>Sat, 28 Jan 2006 12:37:00 PST</pubDate>
        <guid isPermaLink="true">http://www.rxpgnews.com/generalisedanxietydisorder/Pregabalin_Receives_a_Positive_Opinion_from_CHMP_f_3304_3304.shtml</guid>
      </item>


  </channel>
</rss>
